{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:47:27Z","timestamp":1769827647816,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"crossref","award":["320.6750.2020-14-9"],"award-info":[{"award-number":["320.6750.2020-14-9"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04739-6","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:20:55Z","timestamp":1683782455000},"page":"8945-8949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The application of gemcitabine and pirarubicin in patients with non-muscle invasive bladder cancer"],"prefix":"10.1007","volume":"149","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanlong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qidong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hecheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"issue":"1","key":"4739_CR1","first-page":"167","volume":"54","author":"H Azuma","year":"2019","unstructured":"Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Komura K, Uehara H, Minami K, Yamamoto K, Narumi Y (2019) Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer. Int J Oncol 54(1):167\u2013176","journal-title":"Int J Oncol"},{"issue":"11","key":"4739_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/life10110305","volume":"10","author":"E Blinova","year":"2020","unstructured":"Blinova E, Buzdin A, Enikeev D, Roshchin D, Suntsova M, Samyshina E, Drobyshev A, Deryabina O, Demura T, Blinov D (2020) Prognostic role of FGFR3 expression status and tumor-related microRNAs level in association with PD-L1 expression in primary luminal non-muscular invasive bladder carcinoma. Life 10(11):305","journal-title":"Life"},{"key":"4739_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.39339.610000.BE","volume":"335","author":"MD Goodyear","year":"2007","unstructured":"Goodyear MD, Krleza-Jeric K, Lemmens T (2007) The declaration of Helsinki. BMJ 335:624\u2013625","journal-title":"BMJ"},{"issue":"6","key":"4739_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4111\/icu.20210265","volume":"62","author":"MA Han","year":"2021","unstructured":"Han MA, Maisch P, Jung JH, Hwang JE, Narayan V, Cleves A, Hwang EC, Dahm P (2021) Intravesical gemcitabine for non-muscle invasive bladder cancer: an abridged cochrane review. Investig Clin Urol 62(6):623","journal-title":"Investig Clin Urol"},{"issue":"2","key":"4739_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MOU.0000000000000846","volume":"31","author":"LA Hugar","year":"2021","unstructured":"Hugar LA, Gilbert SM, Sexton WJ, Kamat AM, Li R (2021) Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer. Curr Opin Urol 31(2):160\u2013169","journal-title":"Curr Opin Urol"},{"issue":"3","key":"4739_CR6","first-page":"191","volume":"71","author":"FA Mistretta","year":"2019","unstructured":"Mistretta FA, Carrion DM, Nazzani S, V\u00e1squez JL, Fiori C, De Cobelli O, Porpiglia F, Esperto F (2019) Bladder recurrence of primary upper tract urinary carcinoma following nephroureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer. Minerva Urologica e Nefrologica = the Italian Journal of Urology and Nephrology 71(3):191\u2013200","journal-title":"Minerva Urologica e Nefrologica = the Italian Journal of Urology and Nephrology"},{"key":"4739_CR7","doi-asserted-by":"publisher","first-page":"101629","DOI":"10.1016\/j.eucr.2021.101629","volume":"37","author":"LFL Moscoloni","year":"2021","unstructured":"Moscoloni LFL, Santarelli M, Spagnuolo J (2021) Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Gu\u00e9rin (BCG) in non-muscular invasive bladder cancer. Urol Case Reports 37:101629","journal-title":"Urol Case Reports"},{"key":"4739_CR8","unstructured":"Na Y, Ye Z, Sun Y, Sun G (2014) Chinese guidelines for the diagnosis and treatment of urological diseases. People\u2019s Medical Publishing House, Beijing, p 63"},{"issue":"5","key":"4739_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD (2020) Treatment of muscle-invasive and advanced bladder cancer in 2020. CA A Cancer J Clin 70(5):404\u2013423","journal-title":"CA A Cancer J Clin"},{"issue":"3","key":"4739_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.14336\/AD.2020.1109","volume":"12","author":"K-W Shih","year":"2021","unstructured":"Shih K-W, Chen W-C, Chang C-H, Tai T-E, Wu J-C, Huang AC, Liu M-C (2021a) Non-muscular invasive bladder cancer: re-envisioning therapeutic journey from traditional to regenerative interventions. Aging Dis 12(3):868","journal-title":"Aging Dis"},{"issue":"3","key":"4739_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.14336\/AD.2020.1109","volume":"12","author":"K-W Shih","year":"2021","unstructured":"Shih K-W, Chen W-C, Chang C-H, Tai T-E, Wu J-C, Huang AC, Liu M-C (2021b) Non-muscular invasive bladder cancer: re-envisioning therapeutic journey from traditional to regenerative interventions. Aging Dis 12(3):868","journal-title":"Aging Dis"},{"issue":"5","key":"4739_CR12","first-page":"3494","volume":"14","author":"P Song","year":"2022","unstructured":"Song P, Lu N, Zhang J, Gao X, Li X, Li Y, Yang L, Liu Z, Ma K, Dong Q (2022) Cause of death of patients with non-muscular invasive, non-metastatic muscular invasive and metastatic bladder cancer after diagnosis. Am J Transl Res 14(5):3494","journal-title":"Am J Transl Res"},{"issue":"5","key":"4739_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/JU.0000000000000688","volume":"203","author":"RL Steinberg","year":"2020","unstructured":"Steinberg RL, Thomas LJ, Brooks N, Mott SL, Vitale A, Crump T, Rao MY, Daniels MJ, Wang J, Nagaraju S (2020) Multi-institution evaluation of sequential gemcitabine and docetaxel as rescue therapy for nonmuscle invasive bladder cancer. J Urol 203(5):902\u2013909","journal-title":"J Urol"},{"issue":"1","key":"4739_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-019-0530-0","volume":"19","author":"T-W Wang","year":"2019","unstructured":"Wang T-W, Yuan H, Diao W-L, Yang R, Zhao X-Z, Guo H-Q (2019) Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence. BMC Urol 19(1):1\u20135","journal-title":"BMC Urol"},{"issue":"2","key":"4739_CR15","first-page":"326","volume":"52","author":"W-X Yang","year":"2021","unstructured":"Yang W-X, Shao Y-X, Hu X, Xiong S-C, Liu Y, Li X (2021) A Randomized Controlled Study of Intravesical Instillation Therapy of Bacillus Calmette-Gu\u00e9rin vs. Epirubicinin treating non-muscular invasive bladder cancer. Sichuan Da Xue Xue Bao Yi Xue Ban = Journal of Sichuan University Medical Science Edition 52(2):326\u2013333","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban = Journal of Sichuan University Medical Science Edition"},{"issue":"8","key":"4739_CR16","doi-asserted-by":"publisher","first-page":"e23883","DOI":"10.1002\/jcla.23883","volume":"35","author":"R Zhao","year":"2021","unstructured":"Zhao R, Shan J, Nie L, Yang X, Yuan Z, Xu H, Liu Z, Zhou X, Ma W, Shi H (2021) The predictive value of the ratio of the product of neutrophils and hemoglobin to lymphocytes in non-muscular invasive bladder cancer patients with postoperative recurrence. J Clin Lab Anal 35(8):e23883","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"4739_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-020-01943-3","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhang Z-L, Luo M-H, Yang H (2020) Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer. World J Surg Oncol 18(1):1\u20139","journal-title":"World J Surg Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04739-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T20:56:27Z","timestamp":1690491387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04739-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4739"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04739-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of The Second Affiliated Hospital of Xi\u2019an Jiaotong University. Informed consent was obtained from all the study subjects before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}